GO:0000403 Y-form DNA binding: Mechanism & Genes

Y-form DNA binding (GO:0000403) is a molecular function defined as binding to a DNA segment shaped like a Y, where one end contains paired double-stranded DNA and the opposite end contains unpaired DNA strands. This forked or splayed architecture is not a rare curiosity; it is a recurring intermediate in DNA replication, recombination, and repair, and it is recognized by dedicated protein modules that coordinate genome maintenance. Because Y-form DNA sits at the intersection of replication and repair, the proteins that bind it are frequently studied in cancer biology, genome stability, and innate immunity. Researchers encounter Y-form DNA whenever they study replication fork progression, strand invasion, or the processing of branched DNA intermediates. The function is experimentally tractable: purified replication proteins can initiate DNA synthesis on forked templates, and drug-induced topoisomerase cleavage complexes can block fork movement in vivo, providing direct assays for Y-form DNA-dependent events. In parallel, immune sensors such as cGAS can be stimulated by structured DNA, including Y-shaped species, which broadens the relevance of this GO term to inflammation and host defense. This article synthesizes the QuickGO definition of GO:0000403 with verified primary literature to explain what Y-form DNA binding is, which proteins and genes are involved, how the function is regulated, and how CRISPR-based models can be used to interrogate it. The goal is to provide a publication-ready, citable overview for molecular biologists, genome engineers, and translational researchers.

Y-form DNA binding (GO:0000403) is the molecular function of selectively binding to a DNA segment that adopts a Y shape, in which one region is paired double-stranded DNA and the opposite region consists of unpaired DNA strands. This definition captures a structural recognition event rather than a catalytic activity: the protein recognizes the forked or splayed geometry of the DNA, often at replication forks or recombination intermediates, and uses that interaction to organize downstream DNA transactions.

Y-form DNA binding is important because forked DNA structures are obligatory intermediates in DNA replication and recombination, and the proteins that recognize them determine whether these processes proceed faithfully or become sources of genome instability. Defects in fork-associated DNA transactions can block replication, sensitize cells to antitumor drugs, and contribute to cancer and other genome-instability disorders. In addition, structured DNA including Y-shaped species can stimulate innate immune sensors such as cGAS, connecting Y-form DNA recognition to inflammation and antiviral defense. Understanding GO:0000403 therefore informs both fundamental chromosome biology and therapeutic strategies that target replication stress or immune sensing.

The following genes and proteins are representative of the replication, recombination, immune-sensing, and transcription-factor systems in which Y-form DNA binding (GO:0000403) has been studied or mechanistically implicated.

Y-form DNA binding is regulated at multiple levels. Substrate availability is controlled by the cell cycle and by DNA damage, since forked DNA structures appear during replication and at stalled forks. Post-translational modifications and protein-protein interactions can modulate the affinity of replication and repair factors for forked DNA, and drug-induced topoisomerase cleavage complexes can alter fork accessibility and block progression. In innate immunity, the strength of cGAS activation depends on the type and structure of the DNA ligand, with single-stranded HIV-1 SL2 DNA providing limited stimulation compared with other DNA species. Developmental transcription programs, such as those controlled by TALE factors, further illustrate that DNA-binding mode can be switched in a context-dependent manner.

Y-form DNA-binding events are central to replication fork biology, and fork blockage by antitumor drug-induced topoisomerase cleavage complexes can impair replication in vivo. This makes proteins that recognize forked DNA attractive candidates for understanding chemotherapy responses and for developing replication-stress-targeted therapies.

Because forked DNA structures arise during replication and recombination, defects in their recognition or processing can lead to genome instability. Experimental systems such as bacteriophage T4 and T7 have provided mechanistic evidence that fork-associated DNA transactions are essential for faithful replication.

Structured DNA, including Y-shaped species, can influence cGAS activation, and single-stranded HIV-1 SL2 DNA provides limited cGAS stimulation, indicating that DNA structure is a key determinant of immune sensing. Dysregulated sensing of forked or aberrant DNA species may contribute to inflammatory pathology.

TALE factors control an essential zebrafish gene expression program using two distinct functional modes, demonstrating that DNA-binding mode switching is critical for development. Disruption of such programs can inform understanding of developmental disorders linked to transcription factor dysfunction.

Electrophoretic mobility shift assays and fluorescence polarization using synthetic Y-form DNA substrates directly measure binding affinity and specificity. Purified replication proteins can be tested on forked templates to determine whether binding supports initiation of DNA synthesis.

In vitro replication systems using purified proteins and forked DNA templates allow mapping of the site and direction of initial DNA synthesis. In vivo, fork progression and blockage can be monitored in bacteriophage or cellular systems treated with topoisomerase poisons.

cGAS activation can be measured in the presence of different DNA structures, including single-stranded and Y-shaped species, using enzymatic reporter assays. These experiments define how DNA geometry controls innate immune stimulation.

TALE factor function can be dissected using zebrafish genetics combined with transcriptomics to identify target gene programs controlled by distinct DNA-binding modes. Such approaches reveal how forked or splayed DNA recognition contributes to gene regulation.

Researchers studying Y-form DNA binding-related genes often need to determine whether a candidate gene is causally involved in forked DNA recognition, replication fork stability, or immune sensing. Establishing causality requires clean genetic models in which the gene of interest is deleted, mutated, tagged, or overexpressed in a controlled manner, followed by functional assays that measure binding, replication, or signaling outputs.

Y-form DNA binding (GO:0000403) is a structurally defined molecular function that sits at the crossroads of DNA replication, recombination, and innate immunity. The forked DNA architecture is recognized by replication proteins, fork-associated factors, immune sensors such as cGAS, and context-dependent transcription factors like TALE proteins. Because defects in these processes can cause replication stress, genome instability, and inflammatory signaling, the proteins that bind Y-form DNA are important research targets. CRISPR-based knockout, point-mutation, knock-in, and overexpression models provide the causal tools needed to move from correlation to mechanism in Y-form DNA biology. Combined with biochemical binding assays, replication reconstitution, and immune sensing readouts, these models support publication-grade studies and therapeutic hypothesis testing.